Suppr超能文献

多中心、对照、随机临床试验,比较轻度急性憩室炎非抗生素门诊治疗与抗生素标准治疗的疗效和安全性。

Multicentre, controlled, randomized clinical trial to compare the efficacy and safety of ambulatory treatment of mild acute diverticulitis without antibiotics with the standard treatment with antibiotics.

作者信息

Mora Lopez Laura, Ruiz-Edo Neus, Serra Pla Sheila, Pallisera Llovera Anna, Navarro Soto Salvador, Serra-Aracil Xavier

机构信息

Corporació Sanitària Parc Taulí (CSPT). Parc Taulí, Street, 1. PC: 08208, Sabadell, Barcelona, Catalonia, Spain.

出版信息

Int J Colorectal Dis. 2017 Oct;32(10):1509-1516. doi: 10.1007/s00384-017-2879-4. Epub 2017 Aug 14.

Abstract

PURPOSE

Acute diverticulitis (AD) is a highly prevalent disease in Spain. Its chronic-recurrent appearance and high rate of relapse mean that it has a major epidemiological and economic impact on our health system. In spite of this, it has not been studied in any great depth. Reassessing its etiopathology, recent studies have observed that it is an inflammatory disease-not, as classic theories had postulated, an infectious one. In the light of these findings, the suitability of antibiotics for its treatment has been reconsidered. At present, however, the evidence for incorporating these findings into clinical practice guidelines remains insufficient.

METHODS

This study was designed to analyse the safety and efficacy of a non-antibiotic treatment for mild AD. Patients with mild AD (grade 0 in the modified Neff classification) who meet the inclusion criteria will be randomly assigned to one of two outpatient treatment strategies: (a) classical treatment (antibiotics, anti-inflammatories and low-fibre diet) or (b) experimental treatment (anti-inflammatories and low-fibre diet). Clinical controls will be performed at 2, 7, 30, and 90 days. We will determine whether there are any differences in the clinical outcome between groups. The main objective is to demonstrate that antibiotics neither accelerate the resolution of the disease nor decrease the number of complications and/or recurrences in these patients, suggesting that their use may be unnecessary.

CONCLUSIONS

The results of this trial will help to optimize and homogenize the treatment of this highly prevalent disease. However, more studies are required before firm changes can be introduced in international clinical practice guidelines.

TRIAL REGISTRATION

The trial has been registered at the ClinicalTrials.gov database (ID: NCT02785549) and the EU Clinical Trials Register database (EudraCT number: 2016-001596-75).

摘要

目的

急性憩室炎(AD)在西班牙是一种高度流行的疾病。其慢性复发性表现和高复发率意味着它对我们的卫生系统具有重大的流行病学和经济影响。尽管如此,对其尚未进行深入研究。重新评估其病因病理学后,最近的研究发现它是一种炎症性疾病,而非如经典理论所假定的那样是感染性疾病。鉴于这些发现,抗生素治疗该病的适用性已被重新审视。然而目前,将这些发现纳入临床实践指南的证据仍然不足。

方法

本研究旨在分析一种非抗生素治疗轻度AD的安全性和有效性。符合纳入标准的轻度AD患者(改良Neff分类为0级)将被随机分配到两种门诊治疗策略之一:(a)传统治疗(抗生素、抗炎药和低纤维饮食)或(b)试验性治疗(抗炎药和低纤维饮食)。在第2、7、30和90天进行临床对照。我们将确定两组之间临床结果是否存在差异。主要目的是证明抗生素既不会加速疾病的缓解,也不会减少这些患者的并发症和/或复发次数,这表明使用抗生素可能没有必要。

结论

该试验结果将有助于优化和统一这种高度流行疾病的治疗。然而,在国际临床实践指南中做出确切改变之前,还需要更多研究。

试验注册

该试验已在ClinicalTrials.gov数据库(ID:NCT02785549)和欧盟临床试验注册数据库(EudraCT编号:2016 - 001596 - 75)注册。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验